Research & KnowledgeEvent: September 7, 2026
Fluidic Sciences notes that Biointron leveraged Cyto-Mine® to develop a high-efficiency plasma B cell screening workflow.
Published
Signal category
Research & Knowledge
Quote
“Biointron leveraged Cyto-Mine® to develop a high-efficiency plasma B cell screening workflow”
— Fluidic Sciences team
Company
Fluidic Sciences
Tackling complex biology with an end-to-end portfolio – from single‑cell screening to molecular characterization.
- Industry
- Biotechnology Research
- Location
- Royston, GB
- Company size
- 30 employees
As the home of Sphere Bio and Fluidity One‑M, we deliver an end‑to‑end portfolio for complex biology. Move seamlessly from multiplex single‑cell screening to in‑solution biophysics – reducing assumptions and accelerating confident decisions. Follow us and stay tuned for exciting updates ahead. -- For more information, visit our website: fluidic.com Connect with us on X: @FluidicSciences
Founded 2024